8 insiders reported 48 Form 4 transactions for UroGen Pharma Ltd. (URGN) over the past 18 months (most recent 2026-06-24). Recent activity: Schoenberg Mark (Chief Medical Officer) Sell 10,000 shares, Schoenberg Mark (Chief Medical Officer) Buy 10,000 shares, Schoenberg Mark (Chief Medical Officer) Sell 5,222 shares, Schoenberg Mark (Chief Medical Officer) Sell 10,000 shares, Robinson James A. Jr. (Director) Buy 2,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | Schoenberg Mark | Chief Medical Officer | Sell | 10,000 | $350,100 |
| 2026-06-09 | Schoenberg Mark | Chief Medical Officer | Buy | 10,000 | $0 |
| 2026-06-09 | Schoenberg Mark | Chief Medical Officer | Sell | 5,222 | $142,561 |
| 2026-05-11 | Schoenberg Mark | Chief Medical Officer | Sell | 10,000 | $300,000 |
| 2026-02-27 | Robinson James A. Jr. | Director | Buy | 2,000 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Buy | 5,500 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Sell | 2,654 | $52,257 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Buy | 3,333 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Sell | 1,608 | $31,662 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Buy | 6,667 | $0 |
| 2026-02-11 | Smith Jason Drew | General Counsel | Sell | 3,217 | $63,343 |
| 2026-02-04 | Schoenberg Mark | Chief Medical Officer | Sell | 3,686 | $72,577 |
| 2026-02-04 | Schoenberg Mark | Chief Medical Officer | Sell | 1,843 | $36,289 |
| 2026-02-04 | Schoenberg Mark | Chief Medical Officer | Sell | 1,844 | $36,308 |
| 2026-02-03 | Schoenberg Mark | Chief Medical Officer | Buy | 3,333 | $0 |
| 2026-02-03 | Schoenberg Mark | Chief Medical Officer | Buy | 6,666 | $0 |
| 2026-02-03 | Schoenberg Mark | Chief Medical Officer | Buy | 3,334 | $0 |
| 2025-12-01 | WEN LEANA | Director | Buy | 2,000 | $0 |
| 2025-12-01 | Robinson James A. Jr. | Director | Buy | 2,000 | $0 |
| 2025-12-01 | Holden Stuart | Director | Buy | 2,000 | $0 |
| 2025-12-01 | Wildman Daniel George | Director | Buy | 2,000 | $0 |
| 2025-12-01 | BUTITTA CYNTHIA M | Director | Buy | 2,000 | $0 |
| 2025-11-20 | Schoenberg Mark | Chief Medical Officer | Sell | 10,000 | $250,000 |
| 2025-10-09 | Degnan Chris | Chief Financial Officer | Buy | 4,483 | $0 |
| 2025-10-09 | Degnan Chris | Chief Financial Officer | Sell | 2,203 | $37,121 |
Source: SEC Form 4 filings · as of 2026-06-24